- Tytuł:
- PsABIOnd Study and eDaily Substudy Design: Long-Term Effectiveness and Safety of Guselkumab and IL-17 Inhibitors in Routine Clinical Practice in Patients with Psoriatic Arthritis
- Autorzy:
- Źródło:
- Rheumatology and Therapy. 10(2):489-505
Czasopismo naukowe